Raquibul Hannan, M.D., Ph.D., Professor and Chief of Genitourinary Radiation Oncology Service, became fascinated with cancer as an undergraduate at New York University. His curiosity led him to pursue a combined medical degree and Ph.D. at State University of New York at Brooklyn from 1999 to 2006. For his Ph.D. research he worked on the immunology of pancreatic carcinogenesis and discovered a novel marker for pancreatic cancer. Following a medical internship the next year, he completed his residency in radiation oncology at Montefiore Medical Center and Albert Einstein College of Medicine in 2011.
At UT Southwestern Medical Center, Dr. Hannan specializes in radiation treatment of genitourinary (GU) cancers including prostate, kidney, bladder, penile, testicular, and ureteral cancer.
Dr. Hannan is knowledgeable in a range of radiation techniques including IMRT, IGRT, linac-based SRS, SBRT, and intracavitary and interstitial brachytherapy.
As an expert in these areas as well as a leading young researcher on the topic of immunologic effects of radiation treatment and immunotherapy in general, he holds two international patents and has presented his findings at symposiums and conferences around the world.
Dr. Hannan is a member of a number of professional organizations including the American Society of Radiation Oncology (ASTRO), the American Board of Radiology (ABR), the American College of Radiology (ACR), the Radiological Society of North America (RSNA), and the American Society of Clinical Oncology (ASCO).